Literature DB >> 22216507

Digoxin therapy: textbooks, theory and practice.

J K Aronson1, D G Grahame-Smith.   

Abstract

Recommendations for correct therapy with digoxin from twenty-five sources are reviewed. Some recommendations may be unsuitable for use with high bioavailability tablets; some are accompanied by insufficient data relating to factors affecting both the response to digoxin and its handling by the body. Guidelines based on pharmacokinetic and pharmacodynamic principles are suggested to help decide optimal digoxin treatment schedules in the presence and absence of non-cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216507      PMCID: PMC1428900          DOI: 10.1111/j.1365-2125.1976.tb04888.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  45 in total

1.  Serum-digoxin after dosage regimen based on body-weight and renal function.

Authors:  K Kolendorf; N J Christiansen; K Siersbaek-Nielsen; J M Hansen
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

2.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

3.  Pain and CPX elevation after intramuscular digoxin.

Authors:  D J Greenblatt; D W Duhme; J Koch-Weser
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

4.  Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens.

Authors:  R W Jelliffe; J Buell; R Kalaba
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

5.  Absorption of digoxin in patients with malabsorption syndromes.

Authors:  W D Heizer; T W Smith; S E Goldfinger
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

6.  An educational program in digitalis therapy.

Authors:  R I Ogilvie; J Ruedy
Journal:  JAMA       Date:  1972-10-02       Impact factor: 56.272

7.  Digoxin metabolism in obesity.

Authors:  G A Ewy; B M Groves; M F Ball; L Nimmo; B Jackson; F Marcus
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

8.  Factors to consider in planning digoxin therapy.

Authors:  R W Jelliffe
Journal:  J Chronic Dis       Date:  1971-09

9.  Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste.

Authors:  R J White; D A Chamberlain; M Howard; T W Smith
Journal:  Br Med J       Date:  1971-02-13

10.  Multiple dose kinetics and drug dosage in patients with kidney disease.

Authors:  L Dettli; P Spring; S Ryter
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971
View more
  6 in total

1.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

4.  Digitalis: its place in modern therapy.

Authors:  A J Taggart; D G McDevitt
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

5.  Pharmacokinetics and dosagae of digoxin in neonates and infants.

Authors:  L Nyberg; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

6.  Plasma and urinary digoxin in thyroid dysfunction.

Authors:  G M Shenfield; J Thompson; D B Horn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.